Are you Dr. Dietz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-2546Fax+1 323-361-8068
Summary
- Dr. Andrew Dietz, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California, Utah, and Minnesota. He is affiliated with City of Hope Comprehensive Cancer Center and is an Assistant Professor at UC San Diego Sch. of Medicine.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- University of WashingtonResidency, Pediatrics, 2005 - 2008
- University of Minnesota Medical SchoolClass of 2005
Certifications & Licensure
- CA State Medical License 2011 - 2025
- UT State Medical License 2014 - 2016
- MN State Medical License 2008 - 2012
- WA State Medical License 2005 - 2008
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 109 citationsDisease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenitaAndrew C. Dietz, Paul J. Orchard, K. S. Baker, Roger Giller, Sharon A. Savage
Bone Marrow Transplantation. 2011-01-01 - 12 citationsPersonalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.Menachem Bitan, Kwang Woo Ahn, Heather R. Millard, Michael A. Pulsipher, Hisham Abdel-Azim
Biology of Blood and Marrow Transplantation. 2017-09-01 - 37 citationsPooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.John E. Levine, Stephan A. Grupp, Michael A. Pulsipher, Andrew C. Dietz, Susana Rives
Journal for Immunotherapy of Cancer. 2021-08-01
Professional Memberships
- Member